Department of Surgery, University Malaya Medical Centre University of Malaya Kuala Lumpur Malaysia.
Department of Surgery University of Hong Kong Pokfulam Hong Kong.
BJS Open. 2018 Oct 18;3(1):48-55. doi: 10.1002/bjs5.50111. eCollection 2019 Feb.
Mastectomy rates among women with early breast cancer in Asia have traditionally been high. This study assessed trends in the surgical management of young women with early-stage breast cancer in Asian settings. Survival in women treated with breast-conserving surgery (BCS; lumpectomy with adjuvant radiotherapy) and those undergoing mastectomy was compared.
Young women (aged less than 50 years) newly diagnosed with stage I or II (T1-2 N0-1 M0) breast cancer in four hospitals in Malaysia, Singapore and Hong Kong in 1990-2012 were included. Overall survival (OS) was compared for patients treated by BCS and those who had a mastectomy. Propensity score analysis was used to account for differences in demographic, tumour and treatment characteristics between the groups.
Some 63·5 per cent of 3536 women underwent mastectomy. Over a 15-year period, only a modest increase in rates of BCS was observed. Although BCS was significantly associated with favourable prognostic features, OS was not significantly different for BCS and mastectomy; the 5-year OS rate was 94·9 (95 per cent c.i. 93·5 to 96·3) and 92·9 (91·7 to 94·1) per cent respectively. Inferences remained unchanged following propensity score analysis (hazard ratio for BCS mastectomy: 0·81, 95 per cent c.i. 0·64 to 1·03).
The prevalence of young women with breast cancer treated by mastectomy remains high in Asian countries. Patients treated with BCS appear to survive as well as those undergoing mastectomy.
亚洲早期乳腺癌女性的乳房切除术率一直居高不下。本研究评估了亚洲地区年轻早期乳腺癌女性手术治疗的趋势。比较了接受保乳手术(BCS;乳房肿块切除术加辅助放疗)和乳房切除术的患者的生存情况。
纳入了 1990 年至 2012 年期间马来西亚、新加坡和中国香港的四家医院新诊断为 I 期或 II 期(T1-2N0-1M0)乳腺癌的年轻女性(年龄小于 50 岁)。比较了接受 BCS 和接受乳房切除术的患者的总生存(OS)。采用倾向评分分析来解释两组间的人口统计学、肿瘤和治疗特征的差异。
3536 名女性中,63.5%接受了乳房切除术。在 15 年期间,BCS 的比例仅略有增加。尽管 BCS 与有利的预后特征显著相关,但 BCS 和乳房切除术的 OS 无显著差异;5 年 OS 率分别为 94.9%(95%可信区间 93.5 至 96.3)和 92.9%(91.7 至 94.1)。倾向评分分析后结论仍然不变(BCS 比乳房切除术的风险比为 0.81,95%可信区间 0.64 至 1.03)。
亚洲国家接受乳房切除术治疗的年轻乳腺癌女性的比例仍然很高。接受 BCS 治疗的患者似乎与接受乳房切除术的患者一样能够生存。